# Cancer Control Program

> **NIH NIH P30** · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · 2020 · $6,764

## Abstract

CANCER CONTROL (CaC) RESEARCH PROGRAM 
ABSTRACT 
The Cancer Control (CaC) Research Program is a newly restructured transdisciplinary program that serves as 
the hub for cancer control and population science research within the University of New Mexico Cancer Center 
(UNMCC) and the State of New Mexico (NM), our catchment area. The Program's overall goal is to reduce 
cancer incidence, morbidity, and mortality, particularly in the unique multiethnic and underserved populations of 
NM. Disparities research is a cross-cutting theme that fosters scientific focus and synergy across the research 
areas. Through vigorous strategic program planning and evaluation, recruitment of 9 new investigators to 
enhance expertise in molecular epidemiology and behavioral/community intervention, and guidance of the 
UNMCC External Advisory Committee, the CaC Program is now focused on three areas of cancer research: 1) 
Risk Prediction and Risk Reduction; 2) Screening; and 3) Post-Diagnosis Outcomes and Survivorship. Unique 
scientific strengths include research addressing disparities (geographic, race/ethnic, socioeconomic, medically 
underserved), particularly in etiologic, outcome, and intervention studies in Hispanics. By drawing on established 
and new partnerships, the Program is also building research that addresses American Indian cancer disparities 
and priorities identified by NM Tribes, Pueblos, and Indian Nations. Major scientific accomplishments in Risk 
Prediction and Risk Reduction include the identification of social, lifestyle, and genetic factors associated with 
lung cancer risk; gene-environment interactions in melanoma risk; and development and dissemination of a 
novel telehealth strategy for the prevention of hepatocellular cancer. In Screening, members have developed a 
statewide surveillance program of screening and diagnosis for cervical pre-cancer and cancer that informs real- 
world cervical cancer prevention through human papilloma virus (HPV) vaccination, screening practice and 
outcomes. Members have also identified barriers to use of early detection tests in colorectal cancer and have 
developed strategies to overcome these barriers to improve screening in underserved populations. In Post- 
Diagnosis Outcomes and Survivorship, members have identified factors that contribute to disparities in post- 
treatment outcomes and survivorship in endometrial and breast cancer and are developing interventions. Led by 
Linda Cook, PhD and Anita Kinney, PhD, RN, the CaC Program is comprised of 28 members (19 full and 9 
associate) from 7 UNM schools and departments, the Lovelace Respiratory Institute, and the Indian Health 
Service Unit of the Centers for Disease Control whose work is supported by $19,276,863 million in annual direct 
cost funding, of which $15,429,911 million is peer-reviewed and $3,137,820 million is from NCI as of 9/1/2014. 
The discoveries made in this Program have resulted 294 publications, of which 19% are intra-programmatic ...

## Key facts

- **NIH application ID:** 10230663
- **Project number:** 3P30CA118100-15S9
- **Recipient organization:** UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
- **Principal Investigator:** CHERYL LYNN WILLMAN
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $6,764
- **Award type:** 3
- **Project period:** 2005-09-26 → 2021-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10230663

## Citation

> US National Institutes of Health, RePORTER application 10230663, Cancer Control Program (3P30CA118100-15S9). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10230663. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*